Home » VALEANT PHARMACEUTICALS SETTLES GALENIKA DISPUTE
VALEANT PHARMACEUTICALS SETTLES GALENIKA DISPUTE
Valeant Pharmaceuticals International todayannounced
that it has reached an agreement to resolve itslong-standing dispute with the
Health Fund of Serbia and the Republicof Serbia regarding their joint venture,
Galenika. Under theagreement, Valeant collected $28 million of a total of $34
millionagreed to be paid in settlement of the dispute. Valeant expects Serbiato
pay the remaining $6 million in the first quarter of 2007.
Finanzen.net
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May